Korean Guidelines for Diagnosis and Management of Idiopathic Nonspecific Interstitial Pneumonia

Idiopathic nonspecific interstitial pneumonia (iNSIP) is recognized as a distinct entity among various types of idiopathic interstitial pneumonias. It is identified histologically by the nonspecific interstitial pneumonia pattern. A diagnosis of iNSIP is feasible once secondary causes or underlying...

Full description

Saved in:
Bibliographic Details
Main Authors: Yong Suk Jo, Hyun-Kyung Lee, Sun Hyo Park, Joon Sung Joh, Hye Jin Jang, Jong Sun Park
Format: Article
Language:English
Published: The Korean Academy of Tuberculosis and Respiratory Diseases 2025-04-01
Series:Tuberculosis and Respiratory Diseases
Subjects:
Online Access:http://e-trd.org/upload/pdf/trd-2024-0168.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850216795834679296
author Yong Suk Jo
Hyun-Kyung Lee
Sun Hyo Park
Joon Sung Joh
Hye Jin Jang
Jong Sun Park
author_facet Yong Suk Jo
Hyun-Kyung Lee
Sun Hyo Park
Joon Sung Joh
Hye Jin Jang
Jong Sun Park
author_sort Yong Suk Jo
collection DOAJ
description Idiopathic nonspecific interstitial pneumonia (iNSIP) is recognized as a distinct entity among various types of idiopathic interstitial pneumonias. It is identified histologically by the nonspecific interstitial pneumonia pattern. A diagnosis of iNSIP is feasible once secondary causes or underlying diseases are ruled out. Usually presenting with respiratory symptoms such as shortness of breath and cough, iNSIP has a subacute or chronic course. It predominantly affects females aged 50 to 60 years who are non-smokers. Key imaging findings on chest high-resolution computed tomography include bilateral reticular opacities in lower lungs, traction bronchiectasis, reduced lung volumes and, ground-glass opacities. Abnormalities are typically diffuse across both lungs with subpleural distributions. Treatment often involves systemic steroids, either alone or in combination with other immunosuppressants, although evidence supporting effectiveness of these treatments is limited. Prognosis is generally more favorable for iNSIP than for idiopathic pulmonary fibrosis, with many studies reporting a 5-year survival rate above 70%. Antifibrotic agents should be considered in a condition, termed progressive pulmonary fibrosis, where pulmonary fibrosis progressively worsens.
format Article
id doaj-art-81fcde7ca7cd49909c917b0e40a88fac
institution OA Journals
issn 1738-3536
2005-6184
language English
publishDate 2025-04-01
publisher The Korean Academy of Tuberculosis and Respiratory Diseases
record_format Article
series Tuberculosis and Respiratory Diseases
spelling doaj-art-81fcde7ca7cd49909c917b0e40a88fac2025-08-20T02:08:12ZengThe Korean Academy of Tuberculosis and Respiratory DiseasesTuberculosis and Respiratory Diseases1738-35362005-61842025-04-0188223724610.4046/trd.2024.01684913Korean Guidelines for Diagnosis and Management of Idiopathic Nonspecific Interstitial PneumoniaYong Suk Jo0Hyun-Kyung Lee1Sun Hyo Park2Joon Sung Joh3Hye Jin Jang4Jong Sun Park5 Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Republic of Korea Division of Pulmonology, Respiratory Center, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Republic of Korea Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, National Medical Center, Seoul, Republic of Korea Division of Pulmonology, Department of Internal Medicine, Inha University Hospital, Inha University College of Medicine, Incheon, Republic of Korea Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of KoreaIdiopathic nonspecific interstitial pneumonia (iNSIP) is recognized as a distinct entity among various types of idiopathic interstitial pneumonias. It is identified histologically by the nonspecific interstitial pneumonia pattern. A diagnosis of iNSIP is feasible once secondary causes or underlying diseases are ruled out. Usually presenting with respiratory symptoms such as shortness of breath and cough, iNSIP has a subacute or chronic course. It predominantly affects females aged 50 to 60 years who are non-smokers. Key imaging findings on chest high-resolution computed tomography include bilateral reticular opacities in lower lungs, traction bronchiectasis, reduced lung volumes and, ground-glass opacities. Abnormalities are typically diffuse across both lungs with subpleural distributions. Treatment often involves systemic steroids, either alone or in combination with other immunosuppressants, although evidence supporting effectiveness of these treatments is limited. Prognosis is generally more favorable for iNSIP than for idiopathic pulmonary fibrosis, with many studies reporting a 5-year survival rate above 70%. Antifibrotic agents should be considered in a condition, termed progressive pulmonary fibrosis, where pulmonary fibrosis progressively worsens.http://e-trd.org/upload/pdf/trd-2024-0168.pdfinterstitial lung diseaseidiopathic nonspecific interstitial pneumoniadiagnosismanagement
spellingShingle Yong Suk Jo
Hyun-Kyung Lee
Sun Hyo Park
Joon Sung Joh
Hye Jin Jang
Jong Sun Park
Korean Guidelines for Diagnosis and Management of Idiopathic Nonspecific Interstitial Pneumonia
Tuberculosis and Respiratory Diseases
interstitial lung disease
idiopathic nonspecific interstitial pneumonia
diagnosis
management
title Korean Guidelines for Diagnosis and Management of Idiopathic Nonspecific Interstitial Pneumonia
title_full Korean Guidelines for Diagnosis and Management of Idiopathic Nonspecific Interstitial Pneumonia
title_fullStr Korean Guidelines for Diagnosis and Management of Idiopathic Nonspecific Interstitial Pneumonia
title_full_unstemmed Korean Guidelines for Diagnosis and Management of Idiopathic Nonspecific Interstitial Pneumonia
title_short Korean Guidelines for Diagnosis and Management of Idiopathic Nonspecific Interstitial Pneumonia
title_sort korean guidelines for diagnosis and management of idiopathic nonspecific interstitial pneumonia
topic interstitial lung disease
idiopathic nonspecific interstitial pneumonia
diagnosis
management
url http://e-trd.org/upload/pdf/trd-2024-0168.pdf
work_keys_str_mv AT yongsukjo koreanguidelinesfordiagnosisandmanagementofidiopathicnonspecificinterstitialpneumonia
AT hyunkyunglee koreanguidelinesfordiagnosisandmanagementofidiopathicnonspecificinterstitialpneumonia
AT sunhyopark koreanguidelinesfordiagnosisandmanagementofidiopathicnonspecificinterstitialpneumonia
AT joonsungjoh koreanguidelinesfordiagnosisandmanagementofidiopathicnonspecificinterstitialpneumonia
AT hyejinjang koreanguidelinesfordiagnosisandmanagementofidiopathicnonspecificinterstitialpneumonia
AT jongsunpark koreanguidelinesfordiagnosisandmanagementofidiopathicnonspecificinterstitialpneumonia